Brief introduction
Principle
This write up is best read after going through general introduction to MPI explaining functioning of the heart, its blood supply, and principles of this procedure.
Physical stress (e.g., based on treadmill) is the first choice for stress testing as it also tests effort tolerance, which is an independent prognosticator of cardiovascular health. However, in patients in who physical stress is not suitable (e.g,. inability to walk briskly or higher perceived risk of increased myocardial oxygen demand) and adenosine is also not suitable (e.g., because of uncontrolled asthma and COPD), dobutamine based stress test is used.
Dobutamine increases heart rate as well as force of heart contraction thus increasing myocardial oxygen demand similar to physical stress. Likewise, it also causes dilatation of the the intramural arteries. The blood flow through the stenosed epicardial arteries does not increase to the same degree as the relatively normal ones, and this heightened heterogeneity in blood flow between resting and post-stress states is detected through MPI.
The 'stress' part of the test involves continuously infusing dobutamine in escalating fashion over 12 to 15 min till target heart rate is achieved. Sometimes atropine could also be used in an attempt to raise the heart rate. The RP (MIBI or tetrofosmin) is injected with 2 minutes of infusion still remaining. Patient's heart rate and BP are monitored around and during the infusion period.
Indications (conditions in which advised)
- Assessing need for CAG in those with intermediate test results on treadmill test.
- Assessing need for CAG in those with renal failure.
- Baseline assessment before medical therapy and/or revascularization (PCI or CABG surgery).
- Assessing improvement in myocardial perfusion following treatment for CAD and/or IHD.
- Evaluating viability of at-risk myocardium (though cardiac FDG PET is more reliable in this regard).
- Determining prognosis after MI.
- Preoperative stratification of risk for adverse cardiovascular events during non-cardiac surgery
What to expect as part of procedure?
Important steps
-
Rest study
- Patient registration and consent.
- Handing over medical documents to the staff.
- Intravenous (IV) access is established (in form of cannula).
- Radiopharmaceutical (RP) - Sestamibi / tetrofosmin is injected through the IV cannula.
- Waiting time of ~75 min (± 15 min) to allow sufficient time for RP to be taken up and eliminated by all organs. Pass urine just before the scan, and also before that (if needed).
- Scanning process starts wherein, the patient lies on their back on the scanner table. A pair of detectors rotates around the patient's chest region, and the entire procedure lasts for ~30 minutes.
- The acquired images are reviewed to ascertain satisfactory scan quality.
- The scan may have to be repeated especially if there is unacceptable patient movement.
-
Stress study
- RP is injected during the dobutamine infusion (as described above).
- Waiting time of ~75 min (± 15 min) to allow sufficient time for RP to be taken up and eliminated by all organs. Pass urine just before the scan, and also before that (if needed).
- Scanning process is similar to the resting study.
- The acquired images are reviewed to ascertain satisfactory scan quality.
- The scan may have to be repeated especially if there is unacceptable patient movement.
Rest and stress studies can be performed on the same day or on separate days. Splitting study between 2 separate days could result in slightly better image quality and reduction in RP dose, but this could prove inconvenient to some patients.
Discomfort / risks during procedure
- Pain during injections or IV cannula insertion.
- There is risk of extravasation at the time of injections or IV cannula insertion. [Extravasation means that blood leaks through the walls of vein punctured by cannula’s needle].
- There can be some transient side effects like palpitations, chest tightness, heaviness of head, headache, anxiety, etc. These usually completely resolve within 4 to 5 minutes of stopping dobutamine infusion.
Time taken for the entire patient visit
- Typical: 5 hours (either on same day or split between 2 days).
- Be prepared for: 7 hours (either on same day or split between 2 days).